Skip to content
Tuesday, January 31, 2023
Latest:
  • KYORIN and Eisai Enter Into License Agreement Concerning the Development and Marketing of Vibegron, a Treatment for Overactive Bladder, in Four ASEAN Countries
  • The Valens Company to Hold Conference Call to Discuss Financial Results for the First Quarter of 2021
  • AlumiFuel Reduces the Authorized Number of Shares
  • Seqirus Ready to Reinforce Canada’s Influenza Pandemic Preparedness Plans
  • FACT, Inc. Announces Patricia Trompeter as CEO
Biotech Research Report

Biotech Research Report

Know First, Act First

  • Covid-19
  • General
  • Cannabis
  • Fiscal & Financing
  • Pharmaceutical
  • Trending

Fiscal & Financing

BIOTCHNO Fiscal & Financing 

The Valens Company to Hold Conference Call to Discuss Financial Results for the First Quarter of 2021

May 24, 2021June 7, 2021 Raza

  Canada NewsWire KELOWNA, BC , April 1, 2021 /CNW/ – The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the

Read more
BIOTCHNO Fiscal & Financing 

Regor Therapeutics Announces Completion of $90 Million Series B Financing

February 18, 2021April 8, 2021 Bachittar

Regor Therapeutics Announces Completion of $90 Million Series B Financing Canada NewsWire SHANGHAI , Feb. 18, 2021 /CNW/ — Regor

Read more
BIOTCHNO Fiscal & Financing 

The Valens Company to Hold Conference Call to Discuss Financial Results for the Fourth Quarter and Fiscal Year 2020

February 18, 2021April 15, 2021 Bachittar

  Canada NewsWire KELOWNA, BC,Feb. 18, 2021/CNW/ –The Valens Company Inc.(TSX: VLNS) (OTCQX: VLNCF) (the“Company,” “The Valens Company” or“Valens”), a leading

Read more
BIOTCHNO Fiscal & Financing 

Seegene posts unprecedented Q4 and 2020 FY results; writes history by joining trillion-won club

February 18, 2021April 15, 2021 Bachittar

Canada NewsWire SEOUL, South Korea,Feb. 18, 2021/CNW/ —South Korea’sleading molecular diagnostics firm Seegene Inc. (KQ096530) reported preliminary financial results for

Read more
BIOTCHNO Fiscal & Financing 

Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021

February 16, 2021April 15, 2021 Bachittar

  Canada NewsWire DUBLIN,Feb. 16, 2021/CNW/ — Medtronic plc (NYSE:MDT) announced today that it will report financial results for its third

Read more
BIOTCHNO Fiscal & Financing 

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2020

February 11, 2021April 8, 2021 Bachittar

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2020 Canada NewsWire VANCOUVER, BC

Read more
BIOTCHNO Fiscal & Financing 

SQI Diagnostics Announces $4 Million Funding via Warrant Exercise by Insiders

December 30, 2020April 15, 2021 vanessa

Canada NewsWire Company will Use Proceeds for Clinical Development and Commercialization Efforts TORONTO, Dec. 30, 2020/CNW/ – SQI Diagnostics Inc. (TSXV:

Read more

Cannabis

SiliCycle signs a Letter of Intent with the Société Québécoise du Cannabis (SQDC)
BIOTCHNO Cannabis 

SiliCycle signs a Letter of Intent with the Société Québécoise du Cannabis (SQDC)

February 15, 2021April 14, 2021 Bachittar

SiliCycle signs a Letter of Intent with the Société Québécoise du Cannabis (SQDC) QUEBEC CITY , Dec. 15, 2020 /CNW

Nutra Pharma Provides Updates on Progress of their Nerve Agent Countermeasures
BIOTCHNO Cannabis 

Nutra Pharma Provides Updates on Progress of their Nerve Agent Countermeasures

November 18, 2020April 19, 2021 vanessa
  • Disclaimer
  • Privacy Policy
TD Media LLC dba Life Water Media
1415 South Voss Road Suite 110-431 Houston, TX 77057